97th General Assembly, 1st Regular Session

HB 695

  
Prohibits a health benefit plan from requiring a higher out-of-pocket cost for an oral anti-cancer medication than for an intravenously administered cancer medication
Sponsor: Scharnhorst, Dwight (098)
Proposed Effective Date: 8/28/2013
LR Number: 1839H.01I
Last Action: This Bill Replaced with a Substitute Bill - Check Primary Bill - HB 593
04/04/2013 - HCS Reported Do Pass (H)
Bill String: HB 695
Next House Hearing: Hearing not scheduled
Calendar: Bill currently not on a House calendar

Bill Text

1839H.01I

Bill Summary

Bill Summary
HB0695I

Fiscal Note